Sharon M. Jackson
Publications by Year
Research Areas
Renal cell carcinoma treatment, Cancer Genomics and Diagnostics, Renal and related cancers, Genetic and Kidney Cyst Diseases, Corporate Social Responsibility Reporting
Most-Cited Works
- → Variation in genomic landscape of clear cell renal cell carcinoma across Europe(2014)198 cited
- → The role of helix formation in the folding of a fully α-helical coiled coil(1996)104 cited
- → Antiplatelet and antithrombotic efficacy of DMP 728, a novel platelet GPIIb/IIIa receptor antagonist.(1994)103 cited
- → Reduced apoptotic levels in squamous but not basal cell carcinomas correlates with detection of cutaneous human papillomavirus(2002)37 cited
- → Intrinsic chemotherapy resistance to the tubulin‐binding antimitotic agents in renal cell carcinoma(2005)30 cited
- → Design, synthesis, and in vitro activities of benzamide-core glycoprotein IIb/IIIa antagonists: 2,3-Diaminopropionic acid derivatives as surrogates of aspartic acid(1997)18 cited
- → Application of Genomic Sequencing to Refine Patient Stratification for Adjuvant Therapy in Renal Cell Carcinoma(2023)17 cited
- → Lessons from sustainable entrepreneurship towards social innovation in healthcare: how green buildings can promote health and well being(2016)5 cited
- → Skin test wheal size and erythema not reduced by topical antihistamine.(1983)3 cited
- → How Managers Make Sense of CSR: The Impact of Eastern Philosophy in Japanese Owned Transnational Corporations(2012)3 cited